Turn AI ambition across your portfolio into prioritised, measurable value creation.
ScopeRight helps operating partners and portfolio leadership teams create a common AI decision system, validate high-potential use cases, identify reusable capability across the portfolio and mobilise company-specific execution — independent at the decision point.
Portfolio AI is a decision-system problem
Across a portfolio, AI value creation is rarely blocked by a shortage of ideas or vendors. Every company has a list of use cases, every vendor has a proposal. What is missing is a reliable way to decide: which opportunities matter, which are worth funding, what evidence is needed before scaling, what should be stopped, and whether to build, buy or work with a partner.
Without that system, each portfolio company invents its own methodology, business cases are written at different levels of detail, pilots launch without kill criteria — and the fund cannot compare opportunities across companies, let alone build a repeatable playbook.
Typical starting situations
An operations team wants to scope and prioritise AI deployment opportunities across dozens of portfolio companies — and build a roadmap that survives board scrutiny.
An investor in people businesses and professional services sees AI as a direct margin lever, because significant operational and knowledge work is still manual.
A PE-backed company wants to move from fragmented AI tool experimentation to a standardised, AI-native way of working.
Leadership needs to connect AI initiatives to measurable financial and operational value levers — and tell a credible executive and board-level story.
Several companies are piloting similar use cases separately, with no shared learning and no comparable evidence.
Why disconnected local pilots don't compound. When every company runs its own experiments, the fund pays for the same lessons several times. Each pilot answers a local question with local methods, so nothing transfers: no comparable business cases, no shared kill criteria, no reusable partner ecosystem. The portfolio accumulates activity — not evidence. The fix is not centralising implementation; it is centralising how decisions get made.
Standardise at fund level
- Opportunity taxonomy and use-case structuring
- Prioritisation methodology
- Minimum business-case standard
- Portfolio governance and decision cadence
- Evidence and reporting standards
- Pilot and Minimal Viable Agent principles, incl. kill criteria
- Shared learning across companies
- Reusable agents, workflows and approved technology patterns
- Reusable, vetted partner ecosystem
Keep company-specific
- Process redesign
- Operational ownership
- Data and systems
- User adoption and change management
- Solution architecture
- Implementation and delivery
Standardise what can be standardised. Build what creates differentiation.
Portfolio companies often discover similar AI opportunities independently. ScopeRight helps identify which capabilities can be reused across the portfolio, where specialist technology can be deployed repeatedly, and where company-specific customisation or proprietary capability creates additional value.
Portfolio-reusable capability
- Common AI governance and evaluation frameworks
- Approved technology patterns
- Reusable agents and workflows
- Repeatable implementation playbooks
Company-specific configuration
- Integrations and data
- Process variants and controls
- User workflows and adoption
Proprietary capability
- Custom workflows or AI capability where differentiation and economics justify a build
Centralise the decision system and reusable capability. Decentralise what genuinely needs to remain company-specific.
How ScopeRight works across a portfolio
Portfolio opportunity structuring
Bring every company's AI ideas to the same level of detail — workflow, owner, value hypothesis — so opportunities become comparable across the portfolio.
Use-case prioritisation
Score use cases on strategic relevance, business value, feasibility, data readiness, adoption, risk, and speed to evidence — one methodology, fund-wide.
Business-case and readiness assessment
Attach a value hypothesis, KPI and data-readiness view to each prioritised use case, so funding decisions rest on business cases rather than enthusiasm.
Kill criteria
Define upfront when an initiative is stopped. Kill criteria keep the portfolio honest — and free budget and attention for what actually works.
Outside-in Scan
Synchronise the portfolio with what peers, adjacent sectors and AI-native organisations have already learned, so internal assumptions get challenged early.
Minimal Viable Agent validation
Prove the strongest use cases through the smallest working AI-enabled workflow — technical feasibility, user adoption and business value, before scaling.
Build, buy or partner decisions
Once the scope is validated, decide per company how it gets delivered — deploy proven technology, configure specialist solutions, build custom, or bring in a partner — with reusable capability applied wherever it exists.
An illustrative 90-day approach
This timeline is illustrative — the sequence matters more than the exact weeks, and the pace depends on portfolio size and data access.
Days 1–20
Govern & map
- Portfolio governance and decision cadence
- Strategic-priority interviews with company leadership
- Opportunity taxonomy and initial longlist
Days 21–40
Structure & prioritise
- Use-case structuring and value hypotheses
- Feasibility and readiness assessment
- Prioritisation and kill criteria
Days 41–70
Validate
- Launch selected Minimal Viable Agents
- Validate with real users and gather evidence
- Compare delivery options per use case
Days 71–90
Decide & mobilise
- Go, redesign or stop decisions
- Build, buy or partner decisions
- Portfolio roadmap, shared playbook and executive narrative
What you walk away with
- Prioritised opportunity portfolio across companies
- Business owner, value hypothesis and KPI per use case
- Technical and data dependencies
- Adoption implications
- Kill criteria per initiative
- MVA briefs for the strongest use cases
- Build, buy or partner recommendation per validated scope
- Portfolio roadmap and reusable playbook
- Board-level narrative supported by evidence
Playbook
The Private Equity AI Operating Model — as a visual playbook
Prefer to see the operating model rather than read about it? Walk through the interactive playbook: govern, scope and mobilise AI value across portfolio companies.
The services behind the portfolio approach
Each engagement combines the same standardised services — applied at portfolio level, with company-specific depth where it matters.
Explore the AI Field Sprint
Find the AI workflows worth deploying — inside the business.
Benchmark AI opportunities outside your organisation
You don't know what you don't know.
Validate a use case with a Minimal Viable Agent
Evidence before scale: validate one use case end to end.
Compare AI implementation partners
Specialist capability when the validated scope calls for it.
Keep early AI implementation on track
Protect the validated scope during implementation.
Private Equity May Need a New Type of Operating Partner
Embedded AI transformation, vertical software and aligned ownership across a buy-and-build platform.
Frequently asked questions
- How should private-equity firms prioritise AI use cases across portfolio companies?
- Use one fund-level methodology: bring every idea to the same level of detail, score it on the same dimensions (value, feasibility, data readiness, adoption, risk, speed to evidence), and attach an owner and kill criteria before anything launches. Comparability is the point — without it, capital flows to the loudest sponsor rather than the strongest business case.
- What should be centralised at fund level, and what should stay local?
- Centralise the decision system and reusable capability: taxonomy, prioritisation methodology, business-case standards, governance, evidence standards, MVA principles, reusable agents and technology patterns, and the partner ecosystem. Keep execution local: process redesign, data and systems, solution architecture, adoption and operational ownership sit with each company.
- What is the difference between an AI pilot and a Minimal Viable Agent?
- A pilot usually tests whether the technology works. A Minimal Viable Agent is the smallest working AI-enabled workflow that proves technical feasibility, user adoption and business value end to end — with success metrics and kill criteria agreed before it starts.
- How many AI initiatives should a portfolio company run at once?
- Fewer than most run today. One to three validated initiatives with owners, KPIs and kill criteria consistently beat a dozen parallel pilots. The constraint is rarely technology — it is leadership attention, data readiness and adoption capacity.
- How do you decide whether to build, buy or partner?
- After the scope is validated, not before. Once an MVA has shown what the workflow needs, compare delivery options on evidence: build when the capability is strategic, buy when a configurable platform covers the validated workflow, partner when specialist speed or expertise is decisive — chosen independently of any vendor's economics. ScopeRight can execute each path: deploy, configure or build.
Before the next round of pilots, agree on the decision system.
Discuss portfolio-wide AI opportunity prioritisation, a focused scoping sprint for one company, an independent review of current initiatives, or an MVA for one high-potential use case.
Need structure before you spend more on AI?
Book a scoping call and leave with clarity, priorities and a recommended path.